(Total Views: 67)
Posted On: 01/09/2024 1:15:46 PM
Post# of 36245

$SRPT News Article - Sarepta Expects Prelim Gene Therapy Revenue To Be $131M In Q4, $200M For Fiscal Year | Benzinga https://marketwirenews.com/news-releases/sare...61056.html


My Twitter: WhyteStocks